Diamonds and Dogs


Prosensa Holding N.V. (RNA)

Prosensa shares are crashing and burning today, down 70.42% at $7.10. The biopharmaceutical company which focuses on genetic disorders saw its shares fall after announcing that it and partner GlaxoSmithKline's Duchenne muscular dystrophy drug, drisapersen, failed to meet its primary endpoint in late-stage trials. The trial consisted of 186 patients of which 125 would receive drisapersen and 61 the placebo. The primary endpoint was a statistically significant improvement in the six-minute walking distance test. The data demonstrated that there was no statistical difference between the drisapersen and placebo cohort. Shares of Prosensa lost nearly $17.00 today, but are still holding up above their 52-week low of $5.65.

Retractable Technologies Inc. (RVP)

Retractable Technologies is not retracting today, up 76.11% at $3.17. The safety syringe company saw its shares skyrocket after favorable news regarding a litigation was released. After a six year battle, the verdict vindicates Retractable's claim that industry giant Becton, Dickinson and Company illegally engaged in anticompetitive conduct with the intent to acquire or maintain monopoly power in the safety syringe market and engaged in false advertising under the Lanham Act. The jury awarded Retractable $113,508,014.00 in compensatory damages subject to being trebled pursuant to federal statute. Shares of Retractable Technologies reached a new 52-week high of $3.92 intraday.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.